Anti-LY6E/SCA-2 抗体 [EPR26038-105]
Anti-LY6E/SCA-2 antibody [EPR26038-105]
- BOND RX™ Validated
- 20ul selling size
- RabMAb
- Recombinant
- 詳細を見る
Be the first to review this product! Submit a review
|
(4 Publications)
Anti-LY6E/SCA-2 antibody [EPR26038-105] (ab300399) is a rabbit monoclonal antibody detecting LY6E/SCA-2 in Western Blot, IHC-P. Suitable for Human.
- Biophysical QC for unrivalled batch-batch consistency
別名を表示する
9804, RIGE, SCA2, TSA1, LY6E, Lymphocyte antigen 6E, Ly-6E, Retinoic acid-induced gene E protein, Stem cell antigen 2, Thymic shared antigen 1, RIG-E, SCA-2, TSA-1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LY6E/SCA-2 antibody [EPR26038-105] (AB300399)
Immunohistochemical analysis of paraffin-embedded Human ovarian carcin tissue labeling LY6E/SCA-2 with ab300399 at 1/500 (0.956 ug/ml) followed by a ready to use LeicaDS9800 (Bond Polymer Refine Detection) was used. Cytoplasmic staining on human ovarian carcinoma (PMID : 25862760).The section was incubated with ab300399 for 30 mins at room temperature.The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond Polymer Refine Detection) was used.Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LY6E/SCA-2 antibody [EPR26038-105] (AB300399)
Immunohistochemical analysis of paraffin-embedded Human breast carcino tissue labeling LY6E/SCA-2 with ab300399 at 1/500 (0.956 ug/ml) followed by a ready to use LeicaDS9800 (Bond Polymer Refine Detection) was used. Cytoplasmic staining on human breast carcinoma (PMID : 25862760).The section was incubated with ab300399 for 30 mins at room temperature.The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond Polymer Refine Detection) was used.Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LY6E/SCA-2 antibody [EPR26038-105] (AB300399)
Immunohistochemical analysis of paraffin-embedded Human gastric adenoc tissue labeling LY6E/SCA-2 with ab300399 at 1/500 (0.956 ug/ml) followed by a ready to use LeicaDS9800 (Bond Polymer Refine Detection) was used. Cytoplasmic staining on human gastric adenocarcinoma (PMID : 25862760).The section was incubated with ab300399 for 30 mins at room temperature.The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond Polymer Refine Detection) was used.Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LY6E/SCA-2 antibody [EPR26038-105] (AB300399)
Immunohistochemical analysis of paraffin-embedded Human pancreas tissue labeling LY6E/SCA-2 with ab300399 at 1/500 (0.956 ug/ml) followed by a ready to use LeicaDS9800 (Bond Polymer Refine Detection) was used. Negative control : almost no staining on human pancreas (PMID : 25862760).The section was incubated with ab300399 for 30 mins at room temperature.The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond Polymer Refine Detection) was used.Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins
- WB
Supplier Data
Western blot - Anti-LY6E/SCA-2 antibody [EPR26038-105] (AB300399)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
All lanes:
Western blot - Anti-LY6E/SCA-2 antibody [EPR26038-105] (ab300399) at 1/1000 dilution
Lane 1:
Human tonsil tissue lysate
Lane 2:
Human pancreas tissue lysate
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 13 kDa
false
Exposure time: 48s
- WB
Supplier Data
Western blot - Anti-LY6E/SCA-2 antibody [EPR26038-105] (AB300399)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
All lanes:
Western blot - Anti-LY6E/SCA-2 antibody [EPR26038-105] (ab300399) at 1/1000 dilution
Lane 1:
Human ovary tissue lysate 20 µg
Lane 2:
Human thymus tissue lysate 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 13 kDa
false
Exposure time: 8s
関連する標識済み抗体及び組成の異なる製品 (1)
-
Anti-LY6E/SCA-2 antibody [EPR26038-105] (BSA and Azide free)
Reactivity data
製品の詳細
What is this antibody validated in?
Anti-LY6E/SCA-2 antibody [EPR26038-105] (ab300399) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P) in Human samples.
What is the molecular weight of LY6E/SCA-2?
Anti-LY6E/SCA-2 [EPR26038-105] (ab300399) specifically detects a band for LY6E/SCA-2 (UniProt: Q16553) at a molecular weight of 13kDa.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Other related products
We have a range of other formats of antibody clone [EPR26038-105] also available for your convenience: ab300399, Carrier free - ab300411
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
LY6E has a significant impact on immune modulation and viral infection processes. It interacts with other immune-related proteins and contributes to the regulation of T-cell proliferation and differentiation. While LY6E is not a part of a multi-protein complex itself its activity can modify the function of immune cells and potentially alter immune responses. This makes it an important player in the context of both adaptive and innate immunity.
Pathways
LY6E participates in key immune signaling pathways particularly those related to interferon signaling and antiviral defense. It influences these pathways by interacting with components such as interferon-gamma and other cytokines which regulate immune cell behavior and response. LY6E affects the STAT pathway by indirectly modulating the activity of STAT1 a critical protein in immune response highlighting its importance in orchestrating immune dynamics.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (4)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 15:11431 PubMed40180998
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer immunology, immunotherapy : CII 74:4 PubMed39487896
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 22:211 PubMed38419085
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature 619:819-827 PubMed37438530
2023
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com